Santiago Linacero

Hospital Universitario Fundación Alcorcón

Papers

2

Total Citations

14

H-Index

2

About

Santiago Linacero is a leading figure in surgical oncology, with a focused expertise in minimally invasive pancreatic surgery and health economics. His major contributions center on rigorously evaluating the cost-effectiveness of robotic versus laparoscopic techniques, particularly for distal pancreatectomy. As the principal investigator of the landmark national prospective trial ROBOCOSTES, his 2024 study, which has already garnered 10 citations, provides critical evidence comparing the clinical and economic outcomes of these advanced surgical approaches. This work directly addresses the pressing question of whether the higher costs of robotic surgery are justified by improved patient outcomes or reduced complications. By integrating real-world data with health economic modeling, Linacero’s research offers actionable insights for hospital administrators and surgeons, helping to guide resource allocation in high-volume centers. His meticulous approach, including a published correction to ensure data accuracy, underscores his commitment to methodological rigor. With his findings shaping clinical guidelines and sparking debate on surgical value, Linacero is a key voice in the ongoing evolution of evidence-based, cost-conscious surgical practice.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Cost-effectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES
10 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 47
🏛 Institutions: Hospital Universitario Fundación Alcorcón

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago